目的:探讨追踪营养护理方案在达芬奇机器人辅助肝癌术后放疗患者中的应用效果。方法:选取西 安交通大学第一附属医院 2021 年 6 月—2023 年 5 月行达芬奇机器人辅助肝癌术后放疗的 122 例患者,按照随机数 表法分为对照组(61 例,行常规护理方案)和研究组(61 例,行追踪营养护理方案),比较两组患者的营养指标、 生活质量及不良反应发生情况。结果:与护理前相比,护理后两组患者 BMI、血红蛋白(Hb)、白蛋白(Alb)、 总蛋白(TP)均升高,且研究组高于对照组(P<0.05)。与护理前相比,护理后两组患者欧洲癌症研究与治疗组织 生活质量问卷(EORTC QLQ-C30)各项评分均升高,且研究组评分高于对照组(P<0.05)。研究组的不良反应总发 生率低于对照组(P<0.05)。结论:追踪营养护理方案应用于达芬奇机器人辅助肝癌术后放疗患者,可有效改善患 者营养情况,提高生活质量,降低不良反应发生率,值得临床推广。
Objective: To explore the application effect of nutritional follow-up in patients who underwent robotassisted surgery for liver cancer and radiotherapy. Methods: 122 patients who underwent Da Vinci robot-assisted surgery for liver cancer and radiotherapy in the First Affiliated Hospital of Xi’an Jiaotong University from June 2021 to May 2023 were selected. They were divided into the control group (n=61) and the study group (n=61) using a random number table. The control group received conventional nursing, and the study group received nutritional follow-up intervention. The nutritional indicators, quality of life, and occurrence of adverse reactions of patients in the two groups were compared. Results: Compared with that before intervention, BMI, hemoglobin (Hb), albumin (Alb), and total protein (TP) of patients in the two groups were all increased after intervention, and they were higher in the study group than those in the control group (P<0.05). Compared with that before intervention, the scores of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) were increased in the two groups after intervention, and they were higher in the study group than those in the control group (P<0.05). The total incidence rate of adverse reactions was lower in the study group than that in the control group (P<0.05). Conclusion: Application of nutritional follow-up in patients who underwent Da Vinci robot-assisted surgery for liver cancer and radiotherapy can effectively improve nutritional status, quality of life of patients, and reduce the incidence rate of adverse reactions, which is worthy of clinical promotion.
收稿日期:2024-03-13 录用日期:2024-04-17
Received Date: 2024-03-13 Accepted Date: 2024-04-17
基金项目:陕西省重点研发计划项目(2022SF-423)
Foundation Item: Key R&D Plan Project of Shaanxi Province (2022HL09)
通讯作者:魏利敏,Email:limin_w2406@163.com
Corresponding Author: WEI Limin, Email: limin_w2406@163.com
引用格式:魏利敏,金鲜珍,刘萍 . 追踪营养护理方案在机器人辅助肝癌术后放疗患者中的应用研究 [J]. 机器人外科学杂志(中英 文),2024,5(6):1254-1259.
Citation: WEI L M, JIN X Z, LIU P. Nutritional follow-up in patients underwent robot-assisted surgery for liver cancer and radiotherapy[J]. Chinese Journal of Robotic Surgery, 2024, 5(6): 1254-1259.
[1] SUN S J, SUN Y, CHEN R, et al. Diaphragm ultrasound to evaluate the antagonistic effect of sugammadex on rocuronium after liver surgery in patients with different liver Child-Pugh grades: study protocol for a prospective, double-blind, non-randomised controlled trial[J]. BMJ open, 2022, 12(2): e052279.
[2] 曹亚娟 , 张来柱 , 余德才 . 新辅助联合机器人右半肝切除治疗 进展期肝癌 : Laennec 入路联合背侧入路 [J]. 中华腔镜外科杂志 ( 电子版 ), 2022, 15(2): 115-116.
[3] 倪樟男 , 叶真豪 , 张辰皓 , 等 . 肝癌手术患者住院费用及影响因 素分析 [J]. 中国病案 , 2023, 24(9): 67-71.
[4] 白丽娜 , 陶震文 , 安润花 , 等 . 非小细胞肺癌化疗患者应用追踪 营养护理方案的实践 [J]. 中国医药导报 , 2022, 19(33): 172-175.
[5] 谭诗生 , 李杭 , 罗健 , 等 . 欧洲癌症研究与治疗组织研制的生活 质量核心调查问卷第 3 版中文版生活质量调查问卷测评 [J]. 中 国临床康复 , 2006, 10(4): 23-27.
[6] 朱鹏 , 廖威 , 张必翔 , 等 . 机器人肝癌肝切除应用现状与前景 [J]. 外科理论与实践 , 2022, 27(2): 95-99.
[7] Chiou L J, Chen H M, Pan L F, et al. Holiday ratio of hospitalization and 30-day readmission rates among cancer patients after major surgery[J]. Cancer Med, 2022, 11(3): 743-752.
[8] Okuno T, Morizane C, Okusaka T, et al. The influence of major hepatectomy on gemcitabine-based chemotherapy for advanced biliary tract cancer: An exploratory subset analysis of JCOG1113[J]. J Clin Oncol, 2022, 40(4 suppl): 419-419.
[9] 刘于 , 储开岳 , 葛彬彬 , 等 . 红外定位系统 (OPS) 辅助摆位新技术 在肝癌放疗中的应用 [J]. 现代肿瘤医学 , 2022, 30(19): 3556-3559.
[10] 鲁世慧 , 王礼学 , 童金龙 , 等 . 肝癌骨转移瘤应用单次放疗与多 次放疗对癌痛、并发症及生活质量的影响 [J]. 中国肿瘤外科杂 志 , 2023, 15(1): 55-59.
[11] 李豆敏 , 谢静 . 追踪营养护理方案在食管癌术后放疗患者中的 应用研究 [J]. 中国肿瘤临床与康复 , 2020, 27(9): 1124-1128.
[12] 周菲菲 , 黄荣 , 蒋军 , 等 . 立体定向体部放疗联合粒细胞 - 巨噬 细胞集落刺激因子治疗原发性肝癌患者的效果 [J]. 广西医学 , 2023, 45(12): 1408-1413.
[13] De B, Cao H S T, Vauthey J N, et al. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States[J]. Cancer, 2022, 128(13): 2529-2539.
[14] 曹自昌 , 贾彦民 , 张静 , 等 . 立体定向分割放疗方案加用仑伐 替尼治疗原发性肝癌的效果研究 [J]. 中国药物滥用防治杂志 , 2023, 29(3): 486-490.
[15] 钟敏 , 孔菊婷 , 张丽妹 . 营养干预联合放化疗对肝癌患者免 疫功能及临床结局的影响 [J]. 国际护理学杂志 , 2022, 41(23): 4397-4400.
[16] DONG J L, LI Y, XIAO H W, et al. Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy[J]. Cancer Biol Med, 2022, 19(1): 43-55.
[17] 徐晓美 , 沈预程 , 邵春燕 . 唑来膦酸联合局部放疗对原发性肝 癌骨转移患者血清 miR-21、TNF-α 和骨代谢水平的影响 [J]. 胃肠病学和肝病学杂志 , 2021, 30(7): 822-825.
[18] 王亮 , 王旗 , 曹鸿鑫 . 槐耳颗粒联合索拉非尼对晚期肝癌患者免 疫功能及生活质量的影响 [J]. 癌症进展 , 2021, 19(5): 507-510.
[19] 童金龙 , 田小强 , 王礼学 , 等 . 姑息放疗在治疗晚期肝脏恶性肿 瘤中的疗效及生活质量评估 [J]. 现代医学 , 2021, 49(6): 623-629.
[20] 廖威 , 张必翔 , 朱鹏 . 机器人肝切除治疗早期肝癌的相关问题 探讨 [J]. 腹部外科 , 2023, 36(1): 1-5, 11.
[21] ZHANG Z H, WAN Z, ZHU Y, et al. Reply-letter to the editor: Comments on “predictive validity of the GLIM criteria in treatment outcomes in cancer patients with radiotherapy”[J]. Clin Nutr, 2022, 41(6): 1449-1450.